TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups April 18, 1975